Industry Leaders to Come Together to Advance Digital Trials at Veeva TMF Innovation Forum
Veeva Systems (NYSE: VEEV) announced the inaugural Veeva TMF Innovation Forum to be held online on March 10, 2022. The event will gather over 250 experts in trial master file (TMF) management to discuss advancements in digital clinical trials. Key themes include the role of TMF as a strategic asset, leveraging artificial intelligence for process automation, optimizing outsourcing models, and meeting new regulatory requirements. The forum aims to enhance clinical strategy and enable a connected clinical ecosystem.
- Engagement of industry leaders like Alexion, Merck, Takeda, and Seagen at the forum.
- Focus on digitally connected trials to improve speed and cost-effectiveness.
- Integration of AI for enhanced efficiency and quality in clinical processes.
- Addressing regulatory requirements for improved compliance.
- None.
PLEASANTON, Calif., Feb. 23, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from Alexion, Merck & Co., Inc., Takeda, and Seagen will speak at the first-ever Veeva TMF Innovation Forum on March 10, 2022. The one-day online event will bring together more than 250 trial master file (TMF) experts and clinical operations leaders to share best practices for TMF management and discuss advancements toward more connected, digital clinical trials.
The inaugural Veeva TMF Innovation Forum will showcase how leading pharmaceutical companies, emerging biotechs, and CROs are evolving their clinical strategy with an eTMF that enables digital execution, seamless information exchange, and inspection readiness. Key themes include:
- Driving digitally connected clinical trials with TMF as a strategic asset for increased speed and cost-effectiveness
- Leveraging artificial intelligence (AI) to automate processes for greater efficiency and quality
- Optimizing outsourcing models for better collaboration and oversight
- Addressing new regulatory requirements for improved compliance
"TMF leaders are accelerating the shift to digital trials by leveraging innovations in eTMF technologies and new operating models," said Jason Methia, vice president, Vault Clinical Operations strategy at Veeva Systems. "Veeva TMF Innovation Forum will explore the critical role of TMF in enabling a connected clinical ecosystem, which is especially important as companies expand beyond decentralized trial strategies for faster and more efficient studies."
The online event is open to life sciences industry professionals. Learn more and register at veeva.com/TMFInnovationForum.
Additional Information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veevasystems on Twitter: twitter.com/veevasystems
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/industry-leaders-to-come-together-to-advance-digital-trials-at-veeva-tmf-innovation-forum-301488186.html
SOURCE Veeva Systems
FAQ
What is the purpose of the Veeva TMF Innovation Forum?
Who are the key participants in the Veeva TMF Innovation Forum?
When will the Veeva TMF Innovation Forum take place?
How will the forum address the challenges of digital clinical trials?
How can industry professionals register for the Veeva TMF Innovation Forum?
